View drug registration information details.
Items | Registration information |
ID | 301 |
No | 301 |
Brand Name | DIAMIDE 5 MG/ 500 MG |
Ingredients | GLIBENCLAMIDE 5 MG
METFORMIN HYDROCHLORIDE 500 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | BLISTERPACK |
Storage | STORE BELOW 30C, PROTECT FROM LIGHT AND MOISTURE |
Shelf Life | 3 YEARS |
Pack Size | BLISTER PACK OF 12X10"S |
Dispensing Category | Prescription only |
ATC Classification | A10BB01 |
Pharmaceutical Class | ANTIDIBETE |
Indications | AS SECOND LINE THERAPY WHEN DIET, EXCERCISE AND INITIAL TREATMENT WITH A SULFONYLUREA OR METFORMIN DO NOT RESULT IN ADEQUEATE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES. |
Contraindications | PATENT WITH BURN, DIABETIC COMA, SEVERE INFECTION, TYPE 1 DIABETE MELLITUS, KETOSIS, ACUTE AND CHRONIC METABOLIC ACIDOSIS |
Side Effects | ANOREXIA, DIARRHEA, DYSPEPSIA, FLATULENCE, NAUSEA, VOMITTING, PROLONGED HYPOGLYCAEMIA |
Unit Price | - |
EDL |
No |
Description | OBONG, YELLOW FILM - COATED TABLETS, SHALLOW CONVEX FACES, "HD" EMBOSSED AND SCORED ON THE SAME FACE. |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | HOVID BHD |
Country | MALAYSIA |
Import Registration No | MAL09011430 AZ |
Import Registration Date | 2009-01-29 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-03-16 |
FDD Registration No | 09 I 4172/16 |
FDD Registration Date | 2023-06-07 |
Expiry Date | 2026-06-06 |
Back to drug list
|